B4GALT3 and neoplasm: On the other hand, B4GALT3 has been evaluated more in-depth in tumour research than the former and it mainly plays a functional role by directly modifying β1-integrin glycosylation (Chen, et al., 2014; Chang, et al., 2013; Sun, et al., 2016).